chitosan has been researched along with Pulmonary Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, R; Bebawy, M; De Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Hansbro, PM; Tekade, M; Tekade, RK | 1 |
| Fang, B; Mo, S; Tu, M; Wang, J; Zeng, R; Zhang, G; Zhao, J | 1 |
| Du, BX; He, XY; Shi, XY; Xu, FY; Zhou, LL; Zou, Z | 1 |
| Choi, HG; Hwang, HS; Lee, C; Lee, EH; Lee, ES; Lee, S; Seo, J; Thao, LQ; Youn, YS | 1 |
1 review(s) available for chitosan and Pulmonary Fibrosis
| Article | Year |
|---|---|
Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Topics: Animals; Asthma; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Lung Neoplasms; Nanoparticles; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Respiration Disorders; Respiratory Tract Infections | 2017 |
3 other study(ies) available for chitosan and Pulmonary Fibrosis
| Article | Year |
|---|---|
Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis.
Topics: Animals; Bleomycin; Cell Line; Chitosan; Drug Carriers; Female; Humans; Lung; Nanoparticles; Peptide Fragments; Phosphorylcholine; Pulmonary Fibrosis; Rats; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 2; Recombinant Proteins | 2019 |
Chitosan aerosol inhalation alleviates lipopolysaccharide- induced pulmonary fibrosis in rats.
Topics: Administration, Inhalation; Animals; Chitosan; Collagen; Lipopolysaccharides; Lung; Male; Matrix Metalloproteinase 3; Pulmonary Fibrosis; Random Allocation; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1 | 2014 |
Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Topics: Administration, Inhalation; Aerosols; Animals; Bleomycin; Chitosan; Collagen; Hydroxyproline; Imaging, Three-Dimensional; Lactic Acid; Lung; Male; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Fibrosis; Static Electricity; Surface Properties; Tacrolimus; X-Ray Diffraction | 2016 |